Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (21-30 of 397) with videos related to

Pageof 40
Sort By:
BMJ (Clinical Research Ed.)|July 15, 2010
Policy resistance to harm reduction for drug users and potential effect of changeTim Rhodes, Anya Sarang, Peter Vickerman, et al.
Addiction (Abingdon, England)|May 9, 2012
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settingsPeter Vickerman, Natasha Martin, Katy Turner, et al.
Addiction (Abingdon, England)|November 12, 2014
Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base?Peter Vickerman, Kimberly Page, Lisa Maher, et al.
Journal of Gastroenterology and Hepatology|March 27, 2013
How cost-effective is hepatitis C virus treatment for people who inject drugs?Natasha K Martin, Peter Vickerman, Alec Miners, et al.
AIDS Reviews|May 24, 2017
Modeling Combination HCV Prevention among HIV-infected Men Who Have Sex With Men and People Who Inject DrugsNatasha K Martin, Britt Skaathun, Peter Vickerman, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
HCV treatment as prevention in prison: key issuesNatasha K Martin, Peter Vickerman, David Goldberg, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|January 6, 2006
Detection of gonococcal infection : pros and cons of a rapid testPeter Vickerman, Rosanna W Peeling, Charlotte Watts, et al.
Health Economics|December 30, 2020
Modelling the effect of market forces on the impact of introducing human immunodeficiency virus pre-exposure prophylaxis among female sex workersMatthew Quaife, Fern Terris-Prestholt, Zindoga Mukandavire, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2025
Estimating the annual number of hepatitis C virus infections through vertical transmission at country, regional, and global levels: a data synthesis studyAdam Trickey, Adelina Artenie, Jordan J Feld, et al.
BMJ (Clinical Research Ed.)|October 28, 2010
Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research DatabaseRosie Cornish, John Macleod, John Strang, et al.
Pageof 40

Showing results (21-30 of 397) with videos related to

Sort By:
Pageof 40
BMJ (Clinical Research Ed.)|July 15, 2010
Policy resistance to harm reduction for drug users and potential effect of changeTim Rhodes, Anya Sarang, Peter Vickerman, et al.
Addiction (Abingdon, England)|May 9, 2012
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settingsPeter Vickerman, Natasha Martin, Katy Turner, et al.
Addiction (Abingdon, England)|November 12, 2014
Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base?Peter Vickerman, Kimberly Page, Lisa Maher, et al.
Journal of Gastroenterology and Hepatology|March 27, 2013
How cost-effective is hepatitis C virus treatment for people who inject drugs?Natasha K Martin, Peter Vickerman, Alec Miners, et al.
AIDS Reviews|May 24, 2017
Modeling Combination HCV Prevention among HIV-infected Men Who Have Sex With Men and People Who Inject DrugsNatasha K Martin, Britt Skaathun, Peter Vickerman, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
HCV treatment as prevention in prison: key issuesNatasha K Martin, Peter Vickerman, David Goldberg, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|January 6, 2006
Detection of gonococcal infection : pros and cons of a rapid testPeter Vickerman, Rosanna W Peeling, Charlotte Watts, et al.
Health Economics|December 30, 2020
Modelling the effect of market forces on the impact of introducing human immunodeficiency virus pre-exposure prophylaxis among female sex workersMatthew Quaife, Fern Terris-Prestholt, Zindoga Mukandavire, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2025
Estimating the annual number of hepatitis C virus infections through vertical transmission at country, regional, and global levels: a data synthesis studyAdam Trickey, Adelina Artenie, Jordan J Feld, et al.
BMJ (Clinical Research Ed.)|October 28, 2010
Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research DatabaseRosie Cornish, John Macleod, John Strang, et al.
Pageof 40